Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-29

FDA Approved: VOYDEYA — Original Application (Alexion Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved VOYDEYA (danicopan) from Alexion Pharmaceuticals as an oral Factor D inhibitor for adults with paroxysmal nocturnal hemoglobinuria who are being tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOYDEYA (DANICOPAN)

Snippet

ORIG AP for VOYDEYA (DANICOPAN)